Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Scheller

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos One|September 1, 2015
Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic DrugsAnne Michel, Patrick Downey, Xavier Van Damme, et al.
Neuroscience Letters|December 29, 2007
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's diseaseDieter Scheller, Christine Stichel-Gunkel, Hermann Lübbert, et al.
Experimental Neurology|October 19, 2006
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's diseaseDieter Scheller, Piu Chan, Qin Li, et al.
Theoretical Biology & Medical Modelling|September 24, 2015
PDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domainErfan Younesi, Ashutosh Malhotra, Michaela Gündel, et al.
Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.
Acta Neuropathologica|June 15, 2015
A new dopaminergic nigro-olfactory projectionGünter U Höglinger, Daniel Alvarez-Fischer, Oscar Arias-Carrión, et al.
Plos One|November 2, 2018
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosisMarcia Cristina T Dos Santos, Dieter Scheller, Claudia Schulte, et al.
Oncotarget|May 1, 2018
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's diseaseMarcia Cristina T Dos Santos, Miguel Arturo Barreto-Sanz, Bruna Renata S Correia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2020
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's DiseaseCarlo Wilke, Marcia Cristina Teixeira Dos Santos, Claudia Schulte, et al.
Acta Neuropathologica Communications|July 25, 2015
Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpressionMathieu Bourdenx, Sandra Dovero, Michel Engeln, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|September 1, 2015
Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic DrugsAnne Michel, Patrick Downey, Xavier Van Damme, et al.
Neuroscience Letters|December 29, 2007
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's diseaseDieter Scheller, Christine Stichel-Gunkel, Hermann Lübbert, et al.
Experimental Neurology|October 19, 2006
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's diseaseDieter Scheller, Piu Chan, Qin Li, et al.
Theoretical Biology & Medical Modelling|September 24, 2015
PDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domainErfan Younesi, Ashutosh Malhotra, Michaela Gündel, et al.
Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.
Acta Neuropathologica|June 15, 2015
A new dopaminergic nigro-olfactory projectionGünter U Höglinger, Daniel Alvarez-Fischer, Oscar Arias-Carrión, et al.
Plos One|November 2, 2018
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosisMarcia Cristina T Dos Santos, Dieter Scheller, Claudia Schulte, et al.
Oncotarget|May 1, 2018
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's diseaseMarcia Cristina T Dos Santos, Miguel Arturo Barreto-Sanz, Bruna Renata S Correia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2020
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's DiseaseCarlo Wilke, Marcia Cristina Teixeira Dos Santos, Claudia Schulte, et al.
Acta Neuropathologica Communications|July 25, 2015
Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpressionMathieu Bourdenx, Sandra Dovero, Michel Engeln, et al.
Pageof 2